NMRA-335140-501

NMRA-335140-501 · Neumora Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NMRA-335140-501, covering 2026-04-08 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety and Effectiveness of NMRA-335140-501 [Phase 3]